Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 158 results found. Search for [ Adar Poonawalla coronavirus vaccine ]

Results 20 to 40 of 158
BusinessToday.In
November 23, 2020
Vaccine can be easily manufactured, transported and stored at domestic fridge temperature (2-8 degrees C). This means it can be easily distributed using existing medical facilities such as doctor's surgeries and local pharmacies, allowing for the vaccine to be deployed very rapidly, said Oxford University


BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public


BusinessToday.In
November 20, 2020
The current predicament of Delhi has also garnered the attention of the Health Ministry, which said the spike in daily new COVID-19 cases and fatalities in Delhi are having a spillover effect in the NCR regions of Haryana and Rajasthan


Rukmini Rao
November 20, 2020
E-commerce is blurring lines between online and offline with faster digitisation, says Amazon India head Amit Agarwal


BusinessToday.In
November 20, 2020
However, other schools across Maharashtra that don't come under BMC jurisdiction will reopen on November 23.


BusinessToday.In
November 20, 2020
The researchers said that COVID-19 infection rates between March and August across 15 countries, including UK, France, Italy, and Belgium were on an average 6.2 times higher than the reported cases


Associated Press
November 20, 2020
The European commission has sealed deals with several pharmaceutical companies including BioNTech and Pfizer to buy millions of doses of vaccines on behalf of all EU Member States


BusinessToday.In
November 20, 2020
Verizon Media and BuzzFeed have agreed to syndicate content across each other's platforms.They will create an innovation group to explore monetisation opportunities and leverage emerging ad formats, including extended reality and AR applications


BusinessToday.In
November 20, 2020
Adar Poonawalla said if things go according to the plan, the coronavirus vaccine will be available for vulnerable populations by January or February. And, in March or April, the vaccine will enter the market for the general public


Manali
November 18, 2020
Defining the four attributes, Serum Institute of India CEO Adar Poonawalla posted that a good vaccine must be safe, should offer long-term protection against targeted disease, can be transported and stored at a manageable temperature, and lastly, affordable


BusinessToday.In
November 13, 2020
Serum Institute has tied up with five developers that have made 40 million doses of the coronavirus vaccine in the past two months. They are aiming to start manufacturing of Novavax's candidate soon


BusinessToday.In
November 12, 2020
Adar Poonawalla also spoke about what he thinks about vaccines that require ultra-cold storage. He said that it is \"a joke\" and will not work for developing nations


BusinessToday.In
November 11, 2020
The major hurdle for the vaccine is storage and distribution. Pfizer's COVID-19 vaccine candidate needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below


BusinessToday.In
November 7, 2020
India may concentrate its efforts on Bharat Biotech's Covaxin as AstraZeneca's COVID-19 vaccine deliveries may be delayed. The months of November and December could be critical in terms of vaccine availability as a number of companies are likely to publish late-stage trial data


BusinessToday.In
New Delhi, November 5, 2020
Business activity of the micro, small and medium enterprises - which are regarded as the backbone of Indian economy - is fast reaching near-normal levels; China on Tuesday said Indian and Chinese officials are in communication over India's announcement to operate more Vande Bharat Mission (VBM) flights to the country; Chief Minister Arvind Kejriwal on Wednesday said the city has seen a jump in the number of new COVID-19 cases in the last few days and it can be called a \"third wave\". Watch this and more on News Blast.Also Read: COVID-19 vaccine: Bharat Biotech's COVAXIN likely to be launched as early as February 2021


BusinessToday.In
November 5, 2020
The Hyderabad-based company that has developed COVAXIN with Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), had hoped to roll it out in the second quarter of 2021


BusinessToday.In
November 5, 2020
Coronavirus vaccine update: Data compiled by Duke Global Health Innovation Center said that India has pre-ordered 600 million doses of coronavirus vaccine and is now in the process of negotiation for additional 1 billion doses


Shailendra Shukla
New Delhi, November 5, 2020
MSMEs business activity reaching near-normal levels: ReportBusiness activity of the micro, small and medium enterprises - which are regarded as the backbone of Indian economy - is fast reaching near-normal levels, and rapidly adopting digital business tools to drive efficiency and growth, according to a report. Out of 36, 16 states and UTs are witnessing business activity levels higher than pre-COVID times, while Karnataka, Maharashtra, Gujarat, Andhra Pradesh, Tamil Nadu and Delhi are trend...


BusinessToday.In
November 4, 2020
COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla


BusinessToday.In
November 4, 2020
Scientists have developed a vaccine candidate for COVID-19 that produces high levels of antibodies and better immune response in animals. J&J vaccine trials have resumed in Brazil and Mexico has received coronavirus vaccine from CanSino Biologics for late-stage trials


PAGES 2 OF 8  12345